Roche (Sweden)

DyAb: sequence-based antibody design and property prediction in a low-data regime

ABSTRACT Protein therapeutic design and property prediction are frequently hampered by data scarcity. Here we propose a new model, DyAb, that addresses these issues by leveraging a pair-wise representation to predict differences in protein properties, rather than absolute values....